Product Information
Treatment of patients with HER2 overexpressing breast cancer in combination with: Capecitabine, for treatment of patients with advanced or metastatic breast cancer who have progressed on prior trastuzumab therapy in the metastatic setting, HR+ mets BC
Active ingredients -
Product division -
Information Resources
Downloadable Content
More information